MAUNA KEA TECHNOLOGIES (FR:ALMKT)

:ALMKT

ALMKT

MAUNA KEA TECHNOLOGIES

RESEARCH TOOLSreports

Want to see FR:ALMKT full AI Analyst Report?

MAUNA KEA TECHNOLOGIES (ALMKT) Price & Analysis

1 Followers

ALMKT Stock Chart & Stats

€0.08

€0.00(0.00%)

At close: Jan 08 4:00 PM EST

€0.08

€0.00(0.00%)

Day’s Range― - ―

52-Week Range€0.07 - €0.23

Previous CloseN/A

Volume123.00K

Average Volume (3M)830.17K

Market Cap

€29.97M

Enterprise Value€20.71M

Total Cash (Recent Filing)€4.97M

Total Debt (Recent Filing)€12.08M

Price to Earnings (P/E)2.6

Beta0.84

Next Earnings

Oct 08, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.02

Shares Outstanding192,097,270

10 Day Avg. Volume1,028,958

30 Day Avg. Volume830,169

Financial Highlights & Ratios

PEG Ratio>-0.01

Price to Book (P/B)-2.65

Price to Sales (P/S)1.55

P/FCF Ratio-3.24

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)-0.02

Revenue Forecast (FY)€7.75M

Bulls Say, Bears Say

Bulls Say

High Gross MarginsSustained ~75% gross margins indicate durable product-level economics and pricing power for the CLE platform and consumables. High unit margins support attractive lifetime value per installed system and justify reinvestment in sales/service despite current operating losses, improving long-term path to profitability.

Demand ReboundA strong revenue recovery in 2025 shows the market can re-accelerate after setbacks, suggesting resilient clinical demand and opportunity to grow the installed base. If repeatable, this supports recurring consumable and service revenues and a gradual scaling of operating leverage over multiple quarters.

Material DeleveragingSignificant debt reduction reduced near-term refinancing pressure and interest burden, improving solvency dynamics. Lower gross debt enhances financial flexibility to pursue commercialization and service support investments, making the balance sheet less of an immediate constraint on strategic execution.

Bears Say

Negative Operating Cash FlowPersistent negative OCF and FCF mean the business cannot self-fund growth or cover operating needs, creating reliance on external capital. Over the medium term this limits ability to scale sales/service, raises dilution or refinancing risk, and constrains investments needed to expand adoption.

Negative Shareholders' EquityAccumulated deficits and negative equity signal a stressed balance sheet and limited capital buffer. This reduces covenant headroom, limits access to unsecured financing, and raises the prospect that future strategic moves may require dilutive capital raises or restructuring to restore solvency.

Earnings Quality ConcernsA reported net profit that isn't reflected in cash flow suggests nonrecurring or accounting-driven items. This undermines confidence in earnings repeatability and complicates forecasting, making it harder to rely on reported profits when assessing sustainable performance and planning capital allocation.

ALMKT FAQ

What was MAUNA KEA TECHNOLOGIES’s price range in the past 12 months?

MAUNA KEA TECHNOLOGIES lowest stock price was €0.07 and its highest was €0.23 in the past 12 months.

What is MAUNA KEA TECHNOLOGIES’s market cap?

MAUNA KEA TECHNOLOGIES’s market cap is €29.97M.

When is MAUNA KEA TECHNOLOGIES’s upcoming earnings report date?

MAUNA KEA TECHNOLOGIES’s upcoming earnings report date is Oct 08, 2026 which is in 110 days.

How were MAUNA KEA TECHNOLOGIES’s earnings last quarter?

MAUNA KEA TECHNOLOGIES released its earnings results on Apr 22, 2026. The company reported €0.19 earnings per share for the quarter, beating the consensus estimate of N/A by €0.19.

Is MAUNA KEA TECHNOLOGIES overvalued?

According to Wall Street analysts MAUNA KEA TECHNOLOGIES’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does MAUNA KEA TECHNOLOGIES pay dividends?

MAUNA KEA TECHNOLOGIES does not currently pay dividends.

What is MAUNA KEA TECHNOLOGIES’s EPS estimate?

MAUNA KEA TECHNOLOGIES’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does MAUNA KEA TECHNOLOGIES have?

MAUNA KEA TECHNOLOGIES has 192,097,270 shares outstanding.

What happened to MAUNA KEA TECHNOLOGIES’s price movement after its last earnings report?

MAUNA KEA TECHNOLOGIES reported an EPS of €0.19 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.622%.

Which hedge fund is a major shareholder of MAUNA KEA TECHNOLOGIES?

Currently, no hedge funds are holding shares in FR:ALMKT

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

MAUNA KEA TECHNOLOGIES

Mauna Kea Technologies SA operates as a medical device enterprise, producing and distributing its offerings throughout Europe and worldwide. Its product line serves various medical specialties such as gastroenterology, pulmonology, and urology. Central to its portfolio is Cellvizio, an in vivo cellular imaging platform that delivers real-time data. This innovative system assists medical practitioners in tracking disease evolution, evaluating immediate physiological responses, delineating ambiguous tissue areas, and providing guidance during surgical procedures. Founded in 2000, the company's headquarters are situated in Paris, France.